At 40-50% of normal with ME/CFS, improved then relapsed after Efgartigimod
- Condition
- ME/CFS
- At worst
- Moderate (mostly housebound)
- Ill before improving or writing
- Not stated
- Last post
- Nov 2025
In their words
- Condition: ME/CFS
I was able to spend the whole day at the zoo with my family without debilitating PEM or adrenaline dumps at night
In context ↗ - At worst: Moderate
Maybe 40-50% to 85-90%.
In context ↗ - Now: Relapsed
Took about 2-3 months to kick in and then another 2-3 months to wear off completely after our infusions stopped.
In context ↗
Summary
Cedar 34104 took part in an Efgartigimod trial, including an open-label extension, going from about 40-50% of normal to 85-90%: able to work, spend a whole day at the zoo without PEM, with fewer POTS headaches. Improvement took two to three months and wore off completely two to three months after infusions stopped, and they sometimes cannot brush their teeth.
Ask Miruvor AI
What they tried
What they credit
Their words about each treatment
- Efgartigimod · Helped a lot
Maybe 40-50% to 85-90%. Took about 2-3 months to kick in and then another 2-3 months to wear off completely after our infusions stopped.
In context ↗
Approaches: Biologics & antibodies
Their path
How ill they were on the ME/CFS severity scale, estimated from what they describe at each point, in the order they describe; they don’t give enough times to place each step. Hover or tap a point. Dates are when they posted. What the levels mean.
Show as a table
| When | What happened | Where they were | After |
|---|---|---|---|
| — | baseline before the Efgartigimod trialMaybe 40-50% to 85-90%.In context ↗ | Moderate | |
| during the Efgartigimod trial | significant improvement during open-label Efgartigimod trialI was able to spend the whole day at the zoo with my family without debilitating PEM or adrenaline dumps at night, able to work and brain functioning for my job, less POTS headaches.In context ↗ | Near normal | Efgartigimod / Vyvgart |
| — | benefit wore off after infusions stoppedanother 2-3 months to wear off completely after our infusions stoppedIn context ↗ | Moderate |
Symptoms mentioned
Their words about their symptoms
- Post-exertional malaise
without debilitating PEM or adrenaline dumps at night
In context ↗ - POTS & dysautonomia
They didn't consider our lab results or tilt tables (mine and others were resulting negative for POTS after being on the treatment)
In context ↗ - Headaches & migraine
less POTS headaches
In context ↗ - Brain fog
able to work and brain functioning for my job
In context ↗
Ask Miruvor AI
Similar stories
-
Severe ME/CFS, largely in bed, now somewhat better with pacing and low-dose naltrexone
A nurse who caught COVID in March 2021, she paced back to about 80% within five months, then part-time nursing pushed her to severe ME/CFS and she spent 2022 largely in bed. Over the following years she improved slowly to moderate, crediting pacing, low-dose…
-
Housebound with long COVID, now nearly back to normal after Vyvgart trial and ivabradine
Creek 39914 fell ill with COVID and by 2023 was housebound, walking about 2,000 steps a day and crashing from reading. They credit the Vyvgart (efgartigimod) trial and ivabradine with returning to full-time work and walking 6,000 steps. After the trial…
-
Vyvgart brought us back to life (Clare)
Clare, a nurse who was unable to work with Long COVID, joined a Vyvgart (efgartigimod) trial in 2023. She experienced major symptom relief, with her tachycardia significantly improved and her post-exertional malaise lessened, though not a full return to…
-
Not enough detail to draw a path
Vyvgart brought us back to life (Michaelene)
Michaelene took Vyvgart (efgartigimod), an infusion given weekly, for five months in the open-label phase of a Long COVID POTS trial. Michaelene reported no longer meeting criteria for POTS when the trial was abruptly canceled. Once the drug stopped, the…